Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Barry

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1985
Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigsM N Ellis, D W Barry
The American Journal of Medicine|August 29, 1988
Spectrum of antiviral activity and mechanism of action of zidovudine. An overviewP A Furman, D W Barry
Applied Microbiology|May 1, 1973
Resistance to arbovirus challenge in mice immediately after vaccinationJ Casals, S M Buckley, D W Barry
The American Journal of Medicine|July 20, 1982
Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapyC D Sibrack, C McLaren, D W Barry
Infection and Immunity|April 1, 1978
Antibody production and protection against influenza virus in immunodeficient miceS J Lucas, D W Barry, P Kind
The American Journal of Medicine|July 20, 1982
Spectrum of sensitivity of acyclovir of herpes simplex virus clinical isolatesC McLaren, C D Sibrack, D W Barry
Infection and Immunity|December 1, 1974
Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in miceD W Barry, E Staton, R E Mayner
Developments in Biological Standardization|June 1, 1977
Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresisR E Mayner, R J Blackburn, D W Barry
The Journal of Infectious Diseases|November 1, 1983
In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patientsC McLaren, L Corey, C Dekket, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1986
Clinical and laboratory experience with acyclovir-resistant herpes virusesD W Barry, S N Lehrman, M N Ellis
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|February 1, 1985
Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigsM N Ellis, D W Barry
The American Journal of Medicine|August 29, 1988
Spectrum of antiviral activity and mechanism of action of zidovudine. An overviewP A Furman, D W Barry
Applied Microbiology|May 1, 1973
Resistance to arbovirus challenge in mice immediately after vaccinationJ Casals, S M Buckley, D W Barry
The American Journal of Medicine|July 20, 1982
Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapyC D Sibrack, C McLaren, D W Barry
Infection and Immunity|April 1, 1978
Antibody production and protection against influenza virus in immunodeficient miceS J Lucas, D W Barry, P Kind
The American Journal of Medicine|July 20, 1982
Spectrum of sensitivity of acyclovir of herpes simplex virus clinical isolatesC McLaren, C D Sibrack, D W Barry
Infection and Immunity|December 1, 1974
Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in miceD W Barry, E Staton, R E Mayner
Developments in Biological Standardization|June 1, 1977
Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresisR E Mayner, R J Blackburn, D W Barry
The Journal of Infectious Diseases|November 1, 1983
In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patientsC McLaren, L Corey, C Dekket, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1986
Clinical and laboratory experience with acyclovir-resistant herpes virusesD W Barry, S N Lehrman, M N Ellis
Pageof 4